{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","metadata_created":"2019-02-05T23:40:55.756370","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-02-05T23:40:55.756378","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-02-05","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["VIH","VIH au Canada","dépistage du VIH","traitement antirétroviral","traitement","l'épidémie","traitement antirétroviral et la prophylaxie préexposition du VIH","sida","conférence internationale"],"en":["HIV in Canada","HIV","barriers to HIV testing","facilitators to HIV testing","HIV","social drivers of HIV","structural drivers of HIV","antiretroviral treatment","antiretroviral therapy","pre-exposure prophylaxis","prophylaxis for HIV","prophylaxis","antiretroviral therapy"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 41-12, le 3 décembre 2015 : Bonnes nouvelles sur le VIH","en":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"33a08bd6-c609-4f9c-8870-f1f3770c1e3d","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41-12, le 3 décembre 2015 : Bonnes nouvelles sur le VIH","en":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV","language":["en"],"created":"2019-02-05T23:40:57.170911","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-12-december-3-2015-good-news-on-hiv.html","last_modified":null,"position":0,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"27e2ddd6-bf37-4d12-a0c4-7f37709203db","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41-12, le 3 décembre 2015 : Bonnes nouvelles sur le VIH","en":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV","language":["fr"],"created":"2019-02-05T23:40:57.170920","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih.html","last_modified":null,"position":1,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"dfc81753-db75-4e70-8f5b-4e882b2c8098","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41-12, le 3 décembre 2015 : Bonnes nouvelles sur le VIH","en":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV","language":["en"],"created":"2019-02-05T23:40:57.170923","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/15vol41/dr-rm41-12/assets/pdf/15vol41_12-eng.pdf","last_modified":null,"position":2,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9f7bd005-996f-4a01-9c81-d3ea4c42cbb7","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41-12, le 3 décembre 2015 : Bonnes nouvelles sur le VIH","en":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV","language":["fr"],"created":"2019-02-05T23:40:57.170926","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/15vol41/dr-rm41-12/assets/pdf/15vol41_12-fra.pdf","last_modified":null,"position":3,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9b7be623-9992-46b1-bbfe-72b32cf1f4d0","related_relationship":"","name_translated":{"fr":"Le VIH au Canada, de 2009 à 2014","en":"HIV in Canada: 2009 to 2014"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"HIV in Canada: 2009 to 2014","language":["en"],"created":"2019-02-05T23:40:57.170928","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-12-december-3-2015-good-news-on-hiv/ccdr-volume-41-12-december-3-2015-good-news-on-hiv.html","last_modified":null,"position":4,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"584946dc-d66b-4adb-a46a-5b5689beaa38","related_relationship":"","name_translated":{"fr":"Le VIH au Canada, de 2009 à 2014","en":"HIV in Canada: 2009 to 2014"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"HIV in Canada: 2009 to 2014","language":["fr"],"created":"2019-02-05T23:40:57.170930","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih.html","last_modified":null,"position":5,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"831d24fa-e061-4c15-a555-5a17ade0b93d","related_relationship":"","name_translated":{"fr":"Un aperçu des récentes données probantes sur les obstacles et les facteurs favorables au dépistage du VIH","en":"An overview of recent evidence on barriers and facilitators to HIV testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"An overview of recent evidence on barriers and facilitators to HIV testing","language":["en"],"created":"2019-02-05T23:40:57.170933","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-12-december-3-2015-good-news-on-hiv/ccdr-volume-41-12-december-3-2015-good-news-on-hiv-1.html","last_modified":null,"position":6,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"29e91dfd-9ace-45bb-964c-9a733e600c93","related_relationship":"","name_translated":{"fr":"Un aperçu des récentes données probantes sur les obstacles et les facteurs favorables au dépistage du VIH","en":"An overview of recent evidence on barriers and facilitators to HIV testing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"An overview of recent evidence on barriers and facilitators to HIV testing","language":["fr"],"created":"2019-02-05T23:40:57.170935","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih-1.html","last_modified":null,"position":7,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fadcea0d-8b96-42f4-86fd-16bbb01f7815","related_relationship":"","name_translated":{"fr":"Aborder les vecteurs sociaux et structurels du VIH au Canada","en":"Tackling the social and structural drivers of HIV in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tackling the social and structural drivers of HIV in Canada","language":["en"],"created":"2019-02-05T23:40:57.170937","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-12-december-3-2015-good-news-on-hiv/ccdr-volume-41-12-december-3-2015-good-news-on-hiv-2.html","last_modified":null,"position":8,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"626d8753-14bc-4dee-a39a-83e8a80a6d02","related_relationship":"","name_translated":{"fr":"Aborder les vecteurs sociaux et structurels du VIH au Canada","en":"Tackling the social and structural drivers of HIV in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tackling the social and structural drivers of HIV in Canada","language":["fr"],"created":"2019-02-05T23:40:57.170940","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih-2.html","last_modified":null,"position":9,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1f128d02-d5c2-4413-8feb-68432a87ef1e","related_relationship":"","name_translated":{"fr":"Administration précoce du traitement antirétroviral : Quelles sont les données probantes?","en":"Early antiretroviral treatment: What is the evidence?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Early antiretroviral treatment: What is the evidence?","language":["en"],"created":"2019-02-05T23:40:57.170942","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41-12-december-3-2015-good-news-on-hiv/ccdr-volume-41-12-december-3-2015-good-news-on-hiv-3.html","last_modified":null,"position":10,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e849181f-fe8d-4ac8-9e28-ec798cd4afd8","related_relationship":"","name_translated":{"fr":"Administration précoce du traitement antirétroviral : Quelles sont les données probantes?","en":"Early antiretroviral treatment: What is the evidence?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Early antiretroviral treatment: What is the evidence?","language":["fr"],"created":"2019-02-05T23:40:57.170944","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih/rmtc-volume-41-12-3-decembre-2015-bonnes-nouvelles-vih-3.html","last_modified":null,"position":11,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7003894e-869d-4a8e-9dcb-99b56ac00189","related_relationship":"","name_translated":{"fr":" 90−90−90—Une cible ambitieuse de traitement pour aider à mettre fin à l'épidémie du sida. (Document PDF) ","en":" 90−90−90—Anambitious treatment target to help end the AIDS epidemic. (PDF document)Geneva: UNAIDS; 2014"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" 90−90−90—Anambitious treatment target to help end the AIDS epidemic. (PDF document)Geneva: UNAIDS; 2014","language":["en"],"created":"2019-02-05T23:40:57.170946","url":"http://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf","last_modified":null,"position":12,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cbc36490-52eb-406d-a6b4-b1224bbed28d","related_relationship":"","name_translated":{"fr":" 90−90−90—Une cible ambitieuse de traitement pour aider à mettre fin à l'épidémie du sida. (Document PDF) ","en":" 90−90−90—Anambitious treatment target to help end the AIDS epidemic. (PDF document)Geneva: UNAIDS; 2014"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" 90−90−90—Anambitious treatment target to help end the AIDS epidemic. (PDF document)Geneva: UNAIDS; 2014","language":["fr"],"created":"2019-02-05T23:40:57.170949","url":"http://www.unaids.org/sites/default/files/media_asset/90-90-90_fr.pdf","last_modified":null,"position":13,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8a1af248-8cd7-4d81-a289-b860a85ebaaf","related_relationship":"","name_translated":{"fr":" Lignes directrices pour déterminer quand commencer le traitement antirétroviral et la prophylaxie préexposition du VIH","en":" Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","language":["en"],"created":"2019-02-05T23:40:57.170951","url":"http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/","last_modified":null,"position":14,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d88ae422-0d68-47b0-87ea-871b268a632b","related_relationship":"","name_translated":{"fr":" Lignes directrices pour déterminer quand commencer le traitement antirétroviral et la prophylaxie préexposition du VIH","en":" Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","language":["fr"],"created":"2019-02-05T23:40:57.170953","url":"http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/fr/","last_modified":null,"position":15,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6b045e3d-5d6d-4a21-b95c-7edab580e59f","related_relationship":"","name_translated":{"fr":"La 21e conférence internationale sur le sida","en":"21st International AIDS Conference."},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"21st International AIDS Conference.","language":["en"],"created":"2019-02-05T23:40:57.170956","url":"http://www.aids2016.org/","last_modified":null,"position":16,"revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04","resource_type":"website"}],"place_of_publication":[],"num_resources":17,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2015-12-03 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"6d80cc70-1ea2-4c4f-993b-e4ea077b0c29","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 41-12, December 3, 2015: Good news on HIV","revision_id":"6a8b35bb-29aa-46bd-8798-ba984ef09f04"}